Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance (original) (raw)

Gary P. H. HoDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

,

Steven MargossianDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

,

Toshiyasu TaniguchiDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

&

Alan D. D'AndreaDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MassachusettsCorrespondencealan_dandrea@dfci.harvard.edu